Researchers from IDIBELL, HUB, UAB and Hospital del Mar have identified the presence of an ALS biomarker outside the nucleus of skin cells of patients. The discovery can be very useful for cases in which diagnosis is difficult, or in those with a family history of ALS, and even for early diagnosis.
Study of skin biopsies offers potential as new diagnostic marker for ALS Read More »
IDIBELL, together with other scientific institutions in Catalonia, is already part of the Scientific Committee for Pessics de Ciència.
IDIBELL becomes a member of the Pessics de Ciència Scientific Committee Read More »
The second edition of the RECERCLIPS collection explains genetics research at IDIBELL and is presented by the youtuber Juliana Canet.
The glass ceiling, family reconciliation and gender stereotypes are barriers that have had to be overcome, but they have not been an impediment to becoming the leading scientists today.
Research is written in feminine: IDIBELL women and their career Read More »
A study by IDIBELL and ICO, published in the journal Nature Communications, indicates that overexpression of the HMMR gene in women with BRCA1 mutations alters key cellular processes and accelerates the development of breast cancer.
An international team led by IDIBELL and Necker Hospital in Paris has identified mutations in the SLC35B2 gene as responsible for a syndrome that, although very rare and hitherto unknown, could be affecting hundreds of people around the world who would still remain undiagnosed. Symptoms of this disorder include neurodevelopmental delay, motor dysfunctions, and deformity
Researchers identify a gene that causes a new neurological and bone syndrome Read More »
The G9a enzyme increases the probability of developing metastases in these bone or soft tissue neoplasms. However, treatment with its inhibitor (BIX01294) could improve the control of metastasis in patients.
A study published in the journal Scientific Reports, carried out by the Bacterial Epidemiology research group at IDIBELL, Bellvitge Hospital, and CIBERES, has studied the diversity of genes present in clinical strains of H. influenzae serotype f.
A study shows that the pathogen H. influenzae type f is genetically stable Read More »
An article of the IDIBELL and ICO Tumor Angiogenesis Research Group reviews the mechanisms involved in the increased tumor aggressiveness induced by antiangiogenic therapy.
How does antiangiogenic therapy increase the aggressiveness of tumors? Read More »
According to the results of the EMPULSE phase III clinical trial, patients admitted for acute heart failure are 36% more likely to experience improvement within 90 days of receiving treatment with empagliflozin, an existing drug that is mostly prescribed for type 2 diabetes. Dr. Josep Comin, head of the Cardiovascular Disease research group and head
